President, Biometrics Business Unit
Emily Moore has nearly 30 years of leadership experience across global pharmaceutical, nutraceutical, biotech, and contract research organizations (CROs) where she held executive management positions at Novartis, Syneos, and Nestle Health Science.
As President of the Allucent Biometrics team, Emily has responsibility for Biostatistics and Statistical Programming, Data Management, Clinical Programming, and Data Science activities globally.
Emily has lead global Biometrics teams delivering data management strategies and technology innovation across the pharmaceutical, biotech and CRO industry. She has operationalized industry-leading EDC and eCOA technologies and has a track record of leading award-winning teams globally. She brings a wealth of experience in strategic leadership, technological innovation, change management, standardization, and training with a proven track record of driving efficiencies and growth. Moore earned a business and accountancy diploma from Brighton School of Business and Management, and project management certification from the George Washington School of Business.